Literature DB >> 8728143

Etiologic and prevention effectiveness intervention studies in occupational health.

T Skov1, T S Kristensen.   

Abstract

In this article a basic distinction is made between etiologic and prevention effectiveness intervention studies. Etiologic intervention studies focus on elucidating causes of disease, while the purpose of prevention effectiveness intervention studies is to study methods of prevention. The design requirements for each of these studies are very different: etiologic intervention studies usually need large study populations, large exposure contrasts, ascertainment of exposure, as well as health outcome. Ideally, randomization and blinding should also be applied. Effective preventive strategies may, on the other hand, be identified in small study populations with exposure as the only outcome measure, and randomization and blinding may be superfluous. At present, intervention studies are in great demand, and often there is a wish that etiologic questions as well as prevention effectiveness be addressed in the same study. We argue that this should not be done without careful consideration of possible conflicting design aspects.

Mesh:

Year:  1996        PMID: 8728143     DOI: 10.1002/(SICI)1097-0274(199604)29:4<378::AID-AJIM19>3.0.CO;2-Z

Source DB:  PubMed          Journal:  Am J Ind Med        ISSN: 0271-3586            Impact factor:   2.214


  2 in total

Review 1.  Evaluation research in occupational health services: general principles and a systematic review of empirical studies.

Authors:  C T Hulshof; J H Verbeek; F J van Dijk; W E van der Weide; I T Braam
Journal:  Occup Environ Med       Date:  1999-06       Impact factor: 4.402

2.  Design of the Bottom-up Innovation project--a participatory, primary preventive, organizational level intervention on work-related stress and well-being for workers in Dutch vocational education.

Authors:  Roosmarijn M C Schelvis; Karen M Oude Hengel; Noortje M Wiezer; Birgitte M Blatter; Joost A G M van Genabeek; Ernst T Bohlmeijer; Allard J van der Beek
Journal:  BMC Public Health       Date:  2013-08-15       Impact factor: 3.295

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.